Journal of Modern Oncology
ISSN 1815-1434 (Print)
ISSN 1815-1442 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial board
OmniDoctor
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Home
>
Search
>
Author Details
Author Details
Жукова, Людмила Григорьевна
Issue
Section
Title
File
Vol 19, No 4 (2017)
Articles
Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0
(Rus)
Vol 19, No 4 (2017)
Articles
Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case
(Rus)
Vol 20, No 1 (2018)
Articles
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series
(Rus)
Vol 20, No 1 (2018)
Articles
Dermatomyositis and polymyositis in breast cancer patients: a case reports
(Rus)
Vol 20, No 2 (2018)
Articles
Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?
(Rus)
Vol 20, No 2 (2018)
Articles
Ribociclib in 1st line HR+ breast cancer treatment
(Rus)
Vol 21, No 2 (2019)
Articles
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
(Rus)
Vol 21, No 1 (2019)
Articles
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
(Rus)
Vol 21, No 3 (2019)
Articles
Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population
(Rus)
Vol 21, No 3 (2019)
Articles
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
(Rus)
Vol 22, No 4 (2020)
CLINICAL ONCOLOGY
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
(Rus)
Vol 22, No 4 (2020)
CLINICAL ONCOLOGY
Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor
(Rus)
Vol 23, No 1 (2021)
CLINICAL ONCOLOGY
Breast cancer
(Rus)
Vol 23, No 1 (2021)
CLINICAL ONCOLOGY
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
(Rus)
(Eng)
Vol 23, No 1 (2021)
CLINICAL ONCOLOGY
Antiangiogenic therapy for breast cancer with triple negative phenotype
(Rus)
Vol 23, No 4 (2021)
CLINICAL ONCOLOGY
The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
(Rus)
Vol 24, No 3 (2022)
CLINICAL ONCOLOGY
Antitumor response and quality of life: is there a need to sacrifice? Clinical observation: long-term and safe control of the disease using a combination of ribociclib with letrozole. Case report
(Rus)
Vol 25, No 1 (2023)
CLINICAL ONCOLOGY
The effect of CDK4/6 inhibitors on the overall survival in patients with advanced HR+/HER2- BC in the entire population and in special clinical subgroups of unfavorable prognosis: A review
(Rus)
Vol 25, No 2 (2023)
CLINICAL ONCOLOGY
The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study
(Rus)
Vol 24, No 4 (2022)
CLINICAL ONCOLOGY
Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study
(Rus)
Vol 25, No 3 (2023)
CLINICAL ONCOLOGY
Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”
(Rus)
Vol 25, No 4 (2023)
CLINICAL ONCOLOGY
How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review
(Rus)
Vol 26, No 1 (2024)
Articles
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia
(Rus)
Vol 26, No 1 (2024)
Articles
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study
(Rus)
Vol 26, No 2 (2024)
Articles
Effect of internal subtype on the efficacy of CDK4/6 inhibitor therapy in advanced HR+/HER2breast cancer: A review
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP